Pharma pays $35.7 billion in penalties, makes $711 billion in profits.
Pharmaceutical Industry Criminal and Civil Penalties $35.7 billion in penalties $711 billion in profits
Twenty-Five Years of Pharmaceutical Industry Criminal and Civil Penalties: 1991 Through 2015
“To our knowledge, a parent company has never been excluded from participation in Medicare and Medicaid for illegal activities,which endanger the public health and deplete taxpayer-funded programs.
Nor has almost any senior executive been given a jail sentence for leading companies engaged in these illegal activities. Much larger penalties and successful prosecutions of company executives that oversee systemic fraud, including jail sentences if appropriate, are necessary to deter future unlawful behavior.
Otherwise, these illegal but profitable activities will continue to be part of companies’ business model.”
“GlaxoSmithKline to Plead Guilty and Pay $3 Billion to Resolve Fraud Allegations and Failure to Report Safety Data”. justice.gov. 2 July 2012. Retrieved 25 August 2012.
“Justice Department Announces Largest Health Care Fraud Settlement in Its History” (PDF). justice.gov. 2 September 2009. Retrieved 25 August 2012.
Rapidly Increasing Criminal and Civil Monetary Penalties Against the Pharmaceutical Industry: 1991 – 2010.
Public Citizen’s Health Research Group. December 16, 2010
Katie Thomas, Michael S. Schmidt (2 July 2012). “Glaxo Agrees to Pay $3 Billion in Fraud Settlement”.
The New York Times. Retrieved 25 August 2012.
Lavoie, Denise (5 December 2007). “Drug Whistleblower Collects $24M”. cbsnews.com. Retrieved 25 August 2012.
Johnson & Johnson to Pay More Than $2.2 Billion to Resolve Criminal and Civil Investigations”. justice.gov. 4 November 2013. Retrieved 5 March 2015.
“Abbott Labs to Pay $1.5 Billion to Resolve Criminal & Civil Investigations of Off-label Promotion of Depakote”. justice.gov. 7 May 2012. Retrieved 25 August 2012.
“Eli Lilly and Company Agrees to Pay $1.415 Billion to Resolve Allegations of Off-label Promotion of Zyprexa”. justice.gov. 15 January 2009. Retrieved 25 August 2012.
“TAP Pharmaceutical Products Inc. and Seven Others Charged with Health Care Crimes; Company Agrees to Pay $875 Million to Settle Charges”. justice.gov. 3 October 2001. Retrieved 25 August 2012.
“Amgen Inc. Pleads Guilty to Federal Charge in Brooklyn, NY.; Pays $762 Million to Resolve Criminal Liability and False Claims Act Allegations”. justice.gov. 19 December 2012.
Retrieved 20 December 2012.
“GlaxoSmithKline to Plead Guilty & Pay $750 Million to Resolve Criminal and Civil Liability Regarding Manufacturing Deficiencies at Puerto Rico Plant”. justice.gov. 26 October 2010.
Retrieved 25 August 2012.
“Serono to Pay $704 Million for the Illegal Marketing of AIDS Drug”. justice.gov. 17 October 2005. Archived from the original on 2 November 2013. Retrieved 25 August 2012.
“Merck to Pay More than $650 Million to Resolve Claims of Fraudulent Price Reporting and Kickbacks”. justice.gov. 7 February 2008. Retrieved 25 August 2012.
“Office of the Deputy Attorney General” (PDF). justice.gov. 7 November 2008. Retrieved 25 August 2012.
“Allergan Agrees to Plead Guilty and Pay $600 Million to Resolve Allegations of Off-Label Promotion of Botox®”. justice.gov. 1 September 2010. Retrieved 25 August 2012.
“Pharmaceutical Giant AstraZeneca to Pay $520 Million for Off-label Drug Marketing”. justice.gov. 27 April 2010. Retrieved 25 August 2012.
“Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug Marketing and Pricing”. justice.gov. 28 September 2007. Retrieved 25 August 2012.
“$500 million fine for Schering-Plough”. The Philadelphia Inquirer. 18 May 2002. Retrieved 25 August 2012.
Mole, Beth (October 7, 2016). “For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million”. Ars Technica. Retrieved December 3, 2016.
“Schering to Pay $435 Million for the Improper Marketing of Drugs and Medicaid Fraud” (PDF). justice.gov. 29 August 2006. Retrieved 25 August 2012.
“Warner-Lambert to Pay $430 Million to Resolve Criminal & Civil Health Care Liability Relating to Off-Label Promotion”. usdoj.gov. United States Department of Justice. 13 May 2004. Retrieved 30 July 2017.
“Biopharmaceutical Company, Cephalon, to Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing”.
U.S. Department of Justice. 29 September 2008. Retrieved 30 July 2017.
“Novartis Pharmaceuticals Corporation, a US subsidiary of Novartis AG, reaches settlement agreement with US Attorney’s Office”. novartis.com. 30 September 2010. Retrieved 25 August 2012.
Petersen, Melody (21 June 2003). “AstraZeneca Pleads Guilty In Cancer Medicine Scheme”.
nytimes.com. Retrieved 25 August 2012.
“Schering-Plough to Pay $345 Million to Resolve Criminal and Civil Liabilities for Illegal Marketing of Claritin”. justice.gov. 30 July 2004. Retrieved 25 August 2012.
Spread the love
1 comment